Cargando…
Inhibition of JMJD6 by 2‐Oxoglutarate Mimics
Studies on the inhibition of the human 2‐oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2‐oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299220/ https://www.ncbi.nlm.nih.gov/pubmed/34581506 http://dx.doi.org/10.1002/cmdc.202100398 |
_version_ | 1784750912708804608 |
---|---|
author | Islam, Md. Sailful Thinnes, Cyrille C. Holt‐Martyn, James P. Chowdhury, Rasheduzzaman McDonough, Michael A. Schofield, Christopher J. |
author_facet | Islam, Md. Sailful Thinnes, Cyrille C. Holt‐Martyn, James P. Chowdhury, Rasheduzzaman McDonough, Michael A. Schofield, Christopher J. |
author_sort | Islam, Md. Sailful |
collection | PubMed |
description | Studies on the inhibition of the human 2‐oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2‐oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use of mass spectrometry to monitor JMJD6‐catalysed lysine hydroxylation. Notably, some clinically applied prolyl hydroxylase inhibitors also inhibit JMJD6. The results will help enable the development of inhibitors selective for human oxygenases, including JMJD6. |
format | Online Article Text |
id | pubmed-9299220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92992202022-07-21 Inhibition of JMJD6 by 2‐Oxoglutarate Mimics Islam, Md. Sailful Thinnes, Cyrille C. Holt‐Martyn, James P. Chowdhury, Rasheduzzaman McDonough, Michael A. Schofield, Christopher J. ChemMedChem Communications Studies on the inhibition of the human 2‐oxoglutarate dependent oxygenase JMJD6, which is a cancer target, by 2‐oxoglutarate mimics / competitors, including human drugs, drug candidates, and metabolites relevant to cancer are described. JMJD6 assays employed NMR to monitor inhibitor binding and use of mass spectrometry to monitor JMJD6‐catalysed lysine hydroxylation. Notably, some clinically applied prolyl hydroxylase inhibitors also inhibit JMJD6. The results will help enable the development of inhibitors selective for human oxygenases, including JMJD6. John Wiley and Sons Inc. 2021-11-16 2022-01-05 /pmc/articles/PMC9299220/ /pubmed/34581506 http://dx.doi.org/10.1002/cmdc.202100398 Text en © 2021 The Authors. ChemMedChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Communications Islam, Md. Sailful Thinnes, Cyrille C. Holt‐Martyn, James P. Chowdhury, Rasheduzzaman McDonough, Michael A. Schofield, Christopher J. Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title | Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title_full | Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title_fullStr | Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title_full_unstemmed | Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title_short | Inhibition of JMJD6 by 2‐Oxoglutarate Mimics |
title_sort | inhibition of jmjd6 by 2‐oxoglutarate mimics |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299220/ https://www.ncbi.nlm.nih.gov/pubmed/34581506 http://dx.doi.org/10.1002/cmdc.202100398 |
work_keys_str_mv | AT islammdsailful inhibitionofjmjd6by2oxoglutaratemimics AT thinnescyrillec inhibitionofjmjd6by2oxoglutaratemimics AT holtmartynjamesp inhibitionofjmjd6by2oxoglutaratemimics AT chowdhuryrasheduzzaman inhibitionofjmjd6by2oxoglutaratemimics AT mcdonoughmichaela inhibitionofjmjd6by2oxoglutaratemimics AT schofieldchristopherj inhibitionofjmjd6by2oxoglutaratemimics |